Citations

Showing 10 of 108162 citations.

Acute Spinal Pain During an Attempted Lumbar Epidural Blood Patch in Congenital Lumbar Spinal Stenosis and Epidural Lipomatosis
Hooten, W. Michael

Mayo Clinic

Pain Physician | March 24, 2021 | Volume: 1;11 | Issue: 1;1 | Pages: 87-90

10.36076/ppj.2008/11/87 Get It

Congenital lumbar spinal stenosis is an uncommon condition that is often asymptomatic in young adults. Herein, we document the first reported occurrence of acute radicular back pain and associated congenital lumbar spinal stenosis in a healthy 24-year-old woman undergoing an epidural blood patch for treatment of a post-dural puncture headache related to an accidental dural puncture sustained during placement of a labor epidural catheter. The acute pain symptoms were elicited twice with injection of less than 1 mL of fluid into the epidural space during the fluoroscopically assisted epidural blood patch. Subsequent magnetic resonance imaging of the lumbar spine demonstrated shortened pedicle length consistent with severe congenital lumbar spinal stenosis and prominent epidural fat. We speculate that the transient increase in pressure within the epidural compartment following injection of a small amount of fluid could have compressed neural structures resulting in severe radicular pain. The prominent epidural fat could have prevented rapid disbursement of the injected fluid which could have further served to propagate the pressure increase throughout the epidural compartment. The unique radiographic features of congenital spinal stenosis could predispose some patients with this unrecognized condition to develop acute pain upon injection of a small amount of fluid into the epidural compartment. Unrecognized congenital lumbar spinal stenosis is an important addition to the differential diagnosis of acute radicular pain elicited during an epidural blood patch in previously asymptomatic patients. Key words: Epidural blood patch, congenital spinal stenosis, epidural lipomatosis, acute spinal pain
Clostridial Sacroiliitis in a Patient with Fecal Incontinence: A Case Report and Review of the Literature
Weingarten, Toby N., Weingarten, Toby N.

Mayo Clinic

Pain Physician | March 24, 2021 | Volume: 2;11 | Issue: 3;2 | Pages: 249-252

10.36076/ppj.2008/11/249 Get It

Introduction: Image-guided sacroiliac joint injections are frequently employed for both diagnostic and therapeutic relief of low back pain. Case Report: An 83-year-old male with chronic lumbrosacral pain previously responsive to right sacroliac joint injections presented for repeat injection. His medical history included Parkinsonism and stool incontinence. Forty-two hours after the injection, he developed fever, dyspnea, and crepitus on the right buttock and thigh. Surgical debridement was recommended, but the family wished for comfort care only. The patient died hours later. The autopsy revealed Gram positive bacilli consistent with Clostridial myonecrosis. Discussion: Pyogenic sacroiliitis is rare and usually occurs in the setting of trauma, drug abuse, or extraspinal infections. Joint infections with Clostridium have been reported after traumatic events including puncture, surgery, and abrasions. Clostridium spores are resistant to chemical preparations used for skin sterilization and require high heat for destruction. Possible practice guidelines with patients that are stool incontinent include mechanical wash prior to sterile preparation and placement of an occlusive sterile dressing after injection to prevent stool contamination of the needle puncture site. As with all rare complications, large scale studies are needed to better identify risk factors to formulate practice management strategies. Key words: Sacroiliac joint, sacroiliac joint injection, pyogenic sacroilitis, fecal incontinence, clostridium
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer
Muscarella, Peter , McIntyre, Kristi , Rosemurgy, Alexander S. , Ross, Sharona , Richards, Donald , Fisher, William E., Flynn, Patrick J. , Mattson, Alicia, Coeshott, Claire, Roder, Joanna , Cohn, Allen Lee, Rodell, Timothy C., Apelian, David, Group, for the GI-4000 in Pancreas Cancer Study, Bekaii‐Saab, Tanios , Röder, Heinrich , Harrell, Frank E. , Group, for the GI-4000 in Pancreas Cancer Study

Mayo Clinic

Journal of Pancreatic Cancer | March 24, 2021 | Volume: 7 | Issue: 1 | Pages: 8-19

10.1089/pancan.2020.0021 | PMID 33786412 Get It

Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma
Csizmar, Clifford M. , Ansell, Stephen M. , Csizmar, Clifford

Mayo Clinic

International Journal of Molecular Sciences | March 24, 2021 | Volume: 22 | Issue: 7 | Pages: 3302

10.3390/ijms22073302 | PMID 33804869 Get It

Immunotherapy has emerged as a powerful therapeutic strategy for many malignancies, including lymphoma. As in solid tumors, early clinical trials have revealed that immunotherapy is not equally efficacious across all lymphoma subtypes. For example, immune checkpoint inhibition has a higher overall response rate and leads to more durable outcomes in Hodgkin lymphomas compared to non-Hodgkin lymphomas. These observations, combined with a growing understanding of tumor biology, have implicated the tumor microenvironment as a major determinant of treatment response and prognosis. Interactions between lymphoma cells and their microenvironment facilitate several mechanisms that impair the antitumor immune response, including loss of major histocompatibility complexes, expression of immunosuppressive ligands, secretion of immunosuppressive cytokines, and the recruitment, expansion, and skewing of suppressive cell populations. Accordingly, treatments to overcome these barriers are being rapidly developed and translated into clinical trials. This review will discuss the mechanisms of immune evasion, current avenues for optimizing the antitumor immune response, clinical successes and failures of lymphoma immunotherapy, and outstanding hurdles that remain to be addressed.
Making Care Fit in the Lives and Loves of Patients With Chronic Conditions
Kunneman, Marleen , Montori, Víctor M.

Mayo Clinic

JAMA Network Open | March 24, 2021 | Volume: 4 | Issue: 3 | Pages: e211576

10.1001/jamanetworkopen.2021.1576 | PMID 33760083 Get It

Biconvex Patellar Components
Hines, Jeremy T. , Lewallen, David G. , Perry, Kevin I. , Taunton, Michael J. , Pagnano, Mark W. , Abdel, Matthew P. , Abdel, Matthew P , Taunton, Michael J

Mayo Clinic

Journal of Bone and Joint Surgery | March 24, 2021 | Volume: 103 | Issue: 13 | Pages: 1220-1228

10.2106/jbjs.20.01064 | PMID 33760782 Get It

Background: The optimal strategy to address osseous deficiencies of the patella during revision total knee arthroplasty (TKA) remains controversial. One possible solution is a cemented biconvex patellar component used such that the non-articular convexity both improves fixation and makes up for bone loss. The aim of this study was to determine the outcomes of the use of biconvex patellar components in a large series of revision TKAs. Methods: From 1996 to 2014, 262 revision TKAs were performed at a single institution using a biconvex patellar component. Implant survivorship, clinical and radiographic results, and complications were assessed. The mean patient age at the TKA revision was 69 years, and 53% of the patients were female. The mean follow-up was 7 years. Results: The 10-year survivorship free of revision of the biconvex patellar component due to aseptic loosening was 96%. The 10-year survivorship free of any revision of the biconvex patellar component was 87%. The 10-year survivorship free of any rerevision and free of any reoperation was 75% and 70%, respectively. The mean Knee Society Score (KSS) improved from 45.4 before the index revision to 67.7 after it. The mean residual composite thickness seen on the most recent radiographs was 18.1 mm. In addition to the complications leading to revision, the most common complications were periprosthetic patellar fracture (6%), of which 3 required revision; superficial wound infection (6%) requiring antibiotic therapy only or irrigation and debridement; and arthrofibrosis (3%). Conclusions: In this cohort of 262 revision TKAs, biconvex patellar components used to treat marked patellar bone loss demonstrated excellent durability with a 10-year survivorship free of patellar rerevision due to aseptic loosening of 96%. The biconvex patellar components were reliable as evidenced by substantial improvements in clinical outcomes scores and a low risk of complications. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Influence of the Area of the Aqueduct on Quantification of Stroke Volume and Max Velocity in Healthy Volunteers Using Phase Contrast Cine MRI
Zhang, Hongri , Duan, Weike , Wang, Yixin , Elder, Benjamin D. , Duan, Weike, Li, Xiaopan , Li, Xinyu , Cogswell, Petrice M.

Mayo Clinic

No container title available | March 24, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-334057/v1 Get It

Abstract Background: The relationship of the area of the aqueduct on quantification of the aqueductal stroke volume (SV) and max velocity need further investigation. Our aim was to assess the influence of the area of the aqueduct on quantification of the aqueductal SV and max velocity measured with phase contrast magnetic resonance imaging (PC-MRI) within the cerebral aqueduct at the level of the intercollicular sulcus.Materials and Methods: Nine healthy volunteers (mean age 29.6 yrs) were enrolled in the study and brain MRIs were performed on a 3.0T system. Quantitative analysis of aqueductal cerebrospinal fluid (CSF) flow was performed using manual regions of interest (ROI) placement. ROIs were separately drawn for each of 12 phases of the cardiac cycle, and changes in aqueduct size during the cardiac cycle were determined. Stroke volumes were calculated uses the first and ninth aqueductal ROIs and compared to each other. Max velocities at the 12 phases were also collected, and the relationship between the area and max velocity and the impact on SV were analyzed.Results: There was variation in the size of the aqueduct during the cardiac cycle, the first area(S1)was larger than the ninth(S9). The first max velocity(Vmax1)was less than the ninth(Vmax9). Additionally, there was a significant different between the stroke volume calculated using the first aqueductal ROI (SV1) and the ninth(SV9). Conclusions: There is variation in the size of the cerebral aqueduct which is used to calculate stroke volume and other CSF flow parameters during the cardiac cycle. The maximum velocity may be inversely proportional to the area of ​​the aqueduct. In order to establish reliable reference values for CSF flow parameters in future studies, a variable ROI, to account for cardiac cycle variation, should be considered and incorporated.
Percutaneous Occipital Stimulator Lead Tip Erosion: Report of 2 Cases
Trentman, Terrence L.

Mayo Clinic

Pain Physician | March 24, 2021 | Volume: 2;11 | Issue: 3;2 | Pages: 253-256

10.36076/ppj.2008/11/253 Get It

Occipital nerve stimulation is an emerging treatment modality for refractory headache disorders like migraine and cluster headache. Either percutaneous or surgical leads are implanted subcutaneously in the occipital region in an effort to stimulate the distal branches of the occipital nerves (C2-3). A number of complications of this technique have been reported, such as painful direct muscle stimulation and lead migration. We report the first 2 cases of occipital lead erosion. In both cases, the lead erosion occurred many months after implantation. One patient lost a significant amount of weight between the time of implant and lead erosion, while the other patient had no obvious risk factors. One patient underwent lead removal with reimplantation 1 month later; the other was managed with excision of a granuloma at the erosion site and prophylactic antibiotics. Both patients returned to excellent headache control. Lead erosion is a possible complication of occipital stimulation; strategies to reduce the risk of lead erosion are discussed, although further studies are needed to clarify the best surgical techniques. Key words: Headache, occipital stimulation, migraine, cluster headache
Fluoroscopically-Guided Injections to Treat “Kissing Spine” Disease
Lamer, Tim J.

Mayo Clinic

Pain Physician | March 24, 2021 | Volume: 4;11 | Issue: 8;4 | Pages: 549-554

10.36076/ppj.2008/11/549 Get It

Background: Any spine structure that is innervated by afferent nociceptive nerve fibers is a potential pain generator. In the lumbar spine, the most studied pain generators include: sacroiliac joints, the zygapophysial joints, the intervertebral discs, myofascial structures. Anomalous lumbosacral articulations, the spinous processes, and lumbar spine osteophytes are less commonly reported. Objective: To describe the diagnostic and therapeutic features of “kissing spine” disease or Baastrup’s Sign with particular attention to MRI findings and fluoroscopicallyguided injection therapy. Design: A series of 3 patients with axial low back pain presented with exam findings and MRI changes suggestive of pain emanating from adjacent spinous processes that appeared to be in direct contact or very closely opposed. This has been described in the literature as “kissing spine” disease or Baastrup’s sign. Fluoroscopically-guided injections were performed and the responses were studied. Results: The 3 patients had MRI findings consisting of inflammation and/or edema in the spinous processes and surrounding soft tissues. Fluoroscopically-guided injections provided pain relief in all 3 patients. One patient with recurrent pain eventually underwent successful surgical resection of the involved spinous processes. Conclusion: Painful adjacent and closely opposed spinous processes can be a source of axial low back pain. We have described MRI features and the responses to fluoroscopically-guided injections in 3 patients with this condition. Key words: Baastrup’s, kissing spine, spine injection
Action mechanism of the beveled tip aspiration catheter
Liu, Yang , Kallmes, David F. , Liu, Yang

Mayo Clinic

Journal of NeuroInterventional Surgery | March 24, 2021 | Volume: 13 | Issue: 9 | Pages: e18-e18

10.1136/neurintsurg-2021-017531 | PMID 33762404 Get It